| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.09 |